A INTERFERÊNCIA POL�TICA NO COMBATE A COVID-19 NO BRASIL E O USO INDISCRIMINADO DA HIDROXICLOROQUINA SOL�DA COMO AGENTE NEBULIZADOR, NA CIDADE DE MANAUS
Main Article Content
Abstract
The COVID-19 pandemic brought to the world stage several challenges that emanated different positions in driving to contain the advances of the disease. The objective of this research was to analyze the interference of politics in the mechanisms of combating Covid-19 in Brazil, highlighting the indiscriminate use of solid Hydroxychloroquine and the failure to comply with bioethical principles. The methodology used was the deductive method; as for the means, the research was bibliographical and as for the ends, qualitative. The conclusion reached was that there is, at a national and global level, a scientific environment, with competent institutions in the area of '‹'‹health, investing efforts to study ways to contain the advance of the pandemic and protect humanity from chaos and, in another counterpoint, the exposure of political segments and their leaders in Brazil acting with attitudes contrary to the established norms and recommendations. The use of Hydroxychloroquine Nebulization in Amazonas, more precisely in the capital, Manaus, supports the denialist behavior of science coordinated by this movement called "Bolsonarismo".
Article Details
I (we) submit this article which is original and unpublished, of my (our) own authorship, to the evaluation of the Dom Helder Journal of Law, and agree that the related copyrights will become exclusive property of the Journal, being prohibited any partial or total copy in any other part or other printed or online communication vehicle dissociated from the Dom Helder Journal of Law, without the necessary and prior authorization that should be requested in writing to Editor in Chief. I (we) also declare that there is no conflict of interest between the articles theme, the author (s) and enterprises, institutions or individuals.
I (we) recognize that the Dom Helder Journal of Law is licensed under a CREATIVE COMMONS LICENSE.